Abstract
Objective:
We report on 133Xe contamination found in the reusable internal bacteria filter of our xenon ventilation system.
Methods:
Internal bacteria filters (n = 6) were evaluated after approximately 1 mo of normal use. The ventilation system was evacuated twice to eliminate 133Xe in the system before removal of the filter. Upon removal, the filter was monitored using a survey meter with an energy-compensated probe and was imaged on a scintillation camera. The filter was monitored and imaged over several days and was stored in a fume hood.
Results:
Estimated 133Xe activity in each filter immediately after removal ranged from 132 to 2,035 kBq (3.6–55.0 μCi), based on imaging. Initial surface radiation levels ranged from 0.4 to 4.5 μSv/h (0.04–0.45 mrem/h). The 133Xe activity did not readily leave the filter over time (i.e., time to reach half the counts of the initial decay-corrected image ranged from <6 to >72 h). The majority of the image counts (~70%) were seen in 2 distinctive areas in the filter. They corresponded to sites where the manufacturer used polyurethane adhesive to attach the fiberglass filter medium to the filter housing.
Conclusion:
133Xe contamination within the reusable internal bacteria filter of our ventilation system was easily detected by a survey meter and imaging. Although initial activities and surface radiation levels were low, radiation safety practices would dictate that a 133Xe-contaminated bacteria filter be stored preferably in a fume hood until it cannot be distinguished from background before autoclaving or disposal.
As a part of routine monthly maintenance on our xenon ventilation system, we replace its internal bacteria filter (model 1549; A-M Systems, Inc.), which is reused after steam autoclaving. After removal of a bacteria filter that was going to be discarded (i.e., according to the manufacturer’s instructions, the filter can be autoclaved up to 25 times but should be discarded after 1 y of use), monitoring with a survey meter detected radioactivity. We report on 133Xe contamination found in the reusable internal bacteria filter of our xenon ventilation system.
MATERIALS AND METHODS
Each internal bacteria filter (n = 6) (Fig. 1) was evaluated after approximately 1 mo of normal use. The xenon ventilation system (Ventil-Con 3; RADX) was evacuated twice to eliminate 133Xe in the system before removal of the bacteria filter. Upon removal, the filter was immediately placed in a resealable plastic bag and monitored using a survey meter equipped with an energy-compensated probe. The maximum surface radiation level was recorded. The filter was then imaged for 5 min using a scintillation camera equipped with a low-energy all-purpose collimator and 20% energy window centered around 81 keV. The bacteria filter was removed from its resealable plastic bag and stored in a fume hood for several days. It was periodically monitored and imaged during that time. A used 133Xe vial was assayed in a dose calibrator and imaged on the scintillation camera to estimate the 133Xe activity in the bacteria filter. Background images were obtained for all sets of images.
Based on imaging, the polyurethane adhesive used by the manufacturer to attach the fiberglass filter medium to the filter housing was thought to be the primary cause of the 133Xe retention. To confirm this suspicion, a small sample (∼4 × 5 × 15 mm) of the adhesive from a filter was placed in a sealed vial with 133Xe for several days. Upon removal from the vial, the adhesive sample was imaged over several days.
We also evaluated if 133Xe activity was found in the CO2 and moisture absorbers (i.e., soda lime granules and silica gel, respectively, n = 2 for both) on their removal from the ventilation system. After the bacteria filter was changed, each absorber was removed and placed in separate resealable plastic bags. The bags were monitored using a survey meter, and then, like the filter, they were imaged on a scintillation camera. The absorbers were stored in the fume hood with the plastic bag opened for approximately 7 h if 133Xe activity was detected. At that time, they were monitored and imaged.
RESULTS
Estimated 133Xe activity in each bacteria filter immediately after removal ranged from 132 to 2,035 kBq (3.6–55.0 μCi), based on imaging. The higher the estimated 133Xe concentration (MBq/L) of the ventilation system was before evacuation, the higher was the initial filter activity. Initial maximum surface-radiation levels ranged from 0.4 to 4.5 μSv/h (0.04–0.45 mrem/h), which correlated well with the estimated activity (Fig. 2). Background levels were 0.1 μSv/h (0.01 mrem/h). The 133Xe activity did readily leave the filter over time (i.e., time to reach half the counts of the initial decay-corrected image ranged from <6 to >72 h) (Fig. 3).
The majority of the image counts (∼70%) were seen in 2 distinctive areas in the bacteria filter (Fig. 4). They corresponded to sites where the manufacturer used polyurethane adhesive to attach the fiberglass filter medium to the polypropylene filter housing (Fig. 5). To confirm that the adhesive was the primary cause of the 133Xe retention, a sample of the adhesive from a filter was placed in a sealed vial with 133Xe for several days. Imaging of the adhesive on removal from the vial demonstrated that the adhesive retained 133Xe activity, which was released slowly over time, as had been the case with the internal bacteria filters.
One bacteria filter had increased initial 133Xe activity throughout. The increase was probably due to incomplete evacuation of the 133Xe activity from the xenon ventilation system before removal. This would explain its quicker release of 133Xe activity (○ line in Fig. 3) when compared with the other filters.
The moisture absorber showed no detectable 133Xe activity on removal, whereas the CO2 absorber did. The 2 CO2 absorbers had estimated 133Xe activities of 157.7 and 308.8 kBq (4.3 and 8.3 μCi), with low maximum surface-radiation levels of 0.3 and 0.4 μSv/h (0.03 and 0.04 mrem/h), respectively. No detectable 133Xe activity in the CO2 absorber could be found after storage in the fume hood for 7 h.
DISCUSSION
Normally, we think of radioxenon contamination as resulting from a xenon spill (e.g., vial breaks or patient removes mask during ventilation study). We have shown that 133Xe contamination is present in the reusable internal bacteria filter and CO2 absorber of our ventilation system. One would not expect to see this type of contamination—of an inert radioactive gas—in a bacteria filter or CO2 absorber. Because the filter is internal, there is a constant presence of 133Xe in the filter (and the CO2 absorber) if the ventilation system has activity loaded (i.e., does not include activity in the xenon trap), thus allowing time for the 133Xe to adsorb to the plastic contents of the bacteria filter (i.e., primarily to the polyurethane adhesive) and to the CO2 absorber. Radioxenon adsorption to plastic syringes (1,2) and to rubber and plastic stoppers and components (1–5) has been reported. Radioxenon contamination of polystyrene packing materials from 133Xe shipments (5–7), plastic packaging jackets that house shielded 133Xe vials (6), and polyurethane packing materials (8) and activated carbon absorbent packets (9) from 131I capsule shipments (i.e., 131mXe contamination) has been reported.
CONCLUSION
133Xe contamination within the reusable internal bacteria filter and CO2 absorber of our ventilation system was easily detected by survey meters and imaging. Although initial activities and surface radiation levels were low, radiation safety practices would dictate that a 133Xe-contaminated bacteria filter and CO2 absorber be stored preferably in a fume hood until it cannot be distinguished from background before autoclaving or disposal.
Acknowledgments
This study was presented at the 48th annual meeting of the Society of Nuclear Medicine in Toronto, Ontario, Canada, in June 2001.
Footnotes
For correspondence contact: Michael T. Hackett, MS, CNMT, Radiation Safety Office/Nuclear Medicine Service (115-CDD), Department of Veterans Affairs Medical Center, 1101 Veterans Dr., Lexington, KY 40502-2236.
E-mail: michael.hackett{at}med.va.gov